Clinical pharmacology of the steroidal oral contraceptives.
D000293:Adolescent; D000328:Adult; D001943:Breast Neoplasms / Q000139:chemically induced; D002561:Cerebrovascular Disorders / Q000139:chemically induced; D055598:Chemical Phenomena; D002621:Chemistry; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003280:Contraceptives, Oral, Synthetic / Q000009:adverse effects* / Q000494:pharmacology; D045166:Estradiol Congeners / Q000378:metabolism; D004967:Estrogens / Q000172:deficiency; D005260:Female; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D008113:Liver Neoplasms / Q000139:chemically induced; D008875:Middle Aged; D009203:Myocardial Infarction / Q000139:chemically induced; D011183:Postoperative Complications / Q000209:etiology; D011247:Pregnancy; D045167:Progesterone Congeners / Q000378:metabolism; D011372:Progestins / Q000172:deficiency; D011655:Pulmonary Embolism / Q000139:chemically induced; D012306:Risk; D013329:Structure-Activity Relationship; D013923:Thromboembolism / Q000139:chemically induced; D013924:Thrombophlebitis / Q000139:chemically induced; D014594:Uterine Neoplasms / Q000139:chemically induced
D003276:Contraceptives, Oral; D003280:Contraceptives, Oral, Synthetic; D045166:Estradiol Congeners; D004967:Estrogens; D045167:Progesterone Congeners; D011372:Progestins